Holen Sie sich die Stockscreener-App
6.80
3.68%
-0.26
Handel nachbörslich:
6.65
-0.15
-2.21%
Schlusskurs vom Vortag:
$7.06
Offen:
$7.12
24-Stunden-Volumen:
262.92K
Relative Volume:
0.74
Marktkapitalisierung:
$351.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.90M
KGV:
-12.83
EPS:
-0.53
Netto-Cashflow:
$-19.80M
1W Leistung:
-1.16%
1M Leistung:
-3.82%
6M Leistung:
+60.76%
1J Leistung:
+60.00%
1-Tages-Spanne:
$6.66
$7.178
1-Wochen-Bereich:
$6.64
$7.178
52-Wochen-Spanne:
$3.19
$7.4899
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Firmenname
Diamedica Therapeutics Inc
Sektor
Branche
Telefon
(763) 496-5454
Adresse
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Vergleichen Sie DMAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.80 | 364.92M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-30 | Eingeleitet | TD Cowen | Buy |
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-06-22 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Eingeleitet | Oppenheimer | Outperform |
| 2021-02-17 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-30 | Eingeleitet | Guggenheim | Buy |
| 2020-07-08 | Eingeleitet | Maxim Group | Buy |
| 2019-04-30 | Eingeleitet | Dougherty & Company | Buy |
| 2019-03-05 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten
Will DiaMedica Therapeutics Inc. stock attract ESG investorsInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
Is DiaMedica Therapeutics Inc. stock supported by innovation pipeline2025 Macro Impact & AI Powered Market Trend Analysis - newser.com
Is DiaMedica Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Community Consensus Stock Picks - newser.com
What momentum shifts mean for DiaMedica Therapeutics Inc.2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Developing predictive dashboards with DiaMedica Therapeutics Inc. dataEarnings Miss & Safe Swing Trade Setups - newser.com
Short interest data insights for DiaMedica Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Has DiaMedica Therapeutics Inc. formed a bullish divergence2025 Market Outlook & Momentum Based Trading Ideas - newser.com
Can DiaMedica Therapeutics Inc. stock hit analyst price targetsQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Is DiaMedica Therapeutics Inc. stock cheap at current valuation2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
How institutional buying supports DiaMedica Therapeutics Inc. stockGap Up & Community Consensus Stock Picks - newser.com
Will DiaMedica Therapeutics Inc. stock outperform tech sector in 2025IPO Watch & Long-Term Capital Growth Strategies - newser.com
Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionCEO Change & Weekly Market Pulse Updates - newser.com
Can DiaMedica Therapeutics Inc. stock double in next 5 years2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-01 02:03:37 - newser.com
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated at TD Cowen - MarketBeat
Why Wall Street Experts Believe This Biotech Stock Represents a Major Opportunity - Barchart.com
Sector ETF performance correlation with DiaMedica Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-10-31 05:34:37 - newser.com
Why DiaMedica Therapeutics Inc. stock remains on watchlistsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Live market analysis of DiaMedica Therapeutics Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com
What valuation multiples suggest for DiaMedica Therapeutics Inc. stockJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Visual analytics tools that track DiaMedica Therapeutics Inc. performanceJuly 2025 Reactions & Safe Capital Growth Tips - newser.com
Order flow analysis tools used on DiaMedica Therapeutics Inc.2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen By Investing.com - Investing.com South Africa
DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen - Investing.com
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Diamedica Therapeutics Inc-Aktie (DMAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
| STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
| STAHLBERG JAN | 10% Owner |
Aug 20 '25 |
Buy |
5.86 |
71,107 |
416,495 |
7,207,820 |
| STAHLBERG JAN | 10% Owner |
Aug 26 '25 |
Buy |
6.00 |
59,648 |
357,888 |
7,713,693 |
| STAHLBERG JAN | 10% Owner |
Aug 22 '25 |
Buy |
5.96 |
59,788 |
356,576 |
7,315,780 |
| STAHLBERG JAN | 10% Owner |
Aug 27 '25 |
Buy |
6.00 |
50,772 |
304,632 |
7,764,465 |
| STAHLBERG JAN | 10% Owner |
Aug 21 '25 |
Buy |
5.96 |
48,172 |
287,028 |
7,255,992 |
| STAHLBERG JAN | 10% Owner |
Aug 15 '25 |
Buy |
6.00 |
8,233 |
49,398 |
7,136,713 |
| STAHLBERG JAN | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
1,542,857 |
5,400,000 |
6,764,465 |
| Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):